Sign in
4/A

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0000950170-24-096987

Director sold 183,834 shares at an average $42.85 ($7,877,091)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kersten Dirk Director 2024-08-08 Sale 10b5-1 −6,377 $40.74 $259,799 2,043,623 I
Kersten Dirk Director 2024-08-08 Sale 10b5-1 −16,357 $42.97 $702,860 2,027,266 I
Kersten Dirk Director 2024-08-08 Sale 10b5-1 −68,936 $42.87 $2,955,286 1,958,330 I
Kersten Dirk Director 2024-08-09 Sale 10b5-1 −50,736 $42.55 $2,158,817 1,907,594 I
Kersten Dirk Director 2024-08-09 Sale 10b5-1 −40,268 $43.44 $1,749,242 1,867,326 I
Kersten Dirk Director 2024-08-09 Sale 10b5-1 −1,160 $44.04 $51,086 1,866,166 I
Open-market sales · 183,834 sh · avg $42.85 · $7,877,091
Loading xslF345X05/ownership.xml…